Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products. Its surgical solutions provide operating room and perioperative environment product solutions, including surgical procedure trays, drapes and gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon's gloves, procedure kits, and orthopedic implants. Its laboratory and diagnostics offer laboratory and diagnostic product solutions, including point of care testing, analyzers and instrumentation, lab and diagnostic consumables, diagnostic instruments, vital signs monitors, and anatomic pathology and phlebotomy products. It provides its products to domestic and international consumers. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands. It provides logistics and supply chain optimization services to domestic and international consumers. It also provides supply chain optimization services, such as consulting engagements, outsourced warehouse and technology management, put-away-ready packaging, third-party logistics, inventory rationalization, and route planning. The company was founded in 1966 and is based in Northfield, Illinois.

Currency in USD	2026
Operating Income	395.00 Million
Income Before Tax	235.00 Million
Income Tax Expense	96.00 Million
Net Income	139.00 Million
Eps	0.07
Epsdiluted	0.07
Weighted Average Shs Out	856.67 Million
Weighted Average Shs Out Dil	860.89 Million
Research And Development Expenses	N/A
Selling General And Administrative Expenses	1.29 Billion
Depreciation And Amortization	256.00 Million
Interest Expense	168.00 Million
Interest Income	49.00 Million
Net Interest Income	-119 Million
Premiums Earned	N/A
Policyholder Benefits	N/A
Gross Profit	2.21 Billion
Ebitda	651.00 Million
Source	edgar
Ebit	403.00 Million

Medline Inc. Annual Reports (10-K)